Embla Medical hf (OCSE:EMBLA)
kr 35.3 0.8 (2.32%) Market Cap: 15.07 Bil Enterprise Value: 18.38 Bil PE Ratio: 31.89 PB Ratio: 2.86 GF Score: 71/100

Q4 2020 Ossur hf Earnings Call Transcript

Feb 02, 2021 / 08:00AM GMT
Release Date Price: kr46.25 (+0.22%)
Operator

Hello, and welcome to the Ãssur Q4 Results 2020. Today, I'm pleased to present Mr. Jón Sigurdsson, President and CEO; Mr. Sölvason, CFO. (Operator Instructions) Speakers, please begin.

Jón Sigurdsson;ssur hf.;CEO;President
Ã

&

Yes. Thank you. Yes. And I would like to welcome you to the Ãssur investor conference call where we will cover the results for the fourth quarter and the full year of 2020. My name is Jón Sigurdsson, and I'm the President and CEO. And with me here today is Sveinn Sölvason, our CFO.

As said before, we will beginning by going through the highlights for the quarter followed by the highlights for the year and ending with our guidance for 2021. A question-and-answer session will then follow.

Sales in the fourth quarter are in line with the mid-range of our guidance announced in October. Sales in the fourth quarter of 2020 amounted to $170 million, which correspond to about 4% organic decline. We saw a continued sales recovery in October and November, but due to the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot